KASSBERG THOMAS RICHARD (CBO & EVP) sold 0.4% of their position (1.01K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $54.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2024ACC: 0000950170-24-026661
Officer· CBO & EVP
Since Mar 2019
+48.87K
Net shares
Net buyer
$69.1K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
50.16K acquired · 1.28K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+17.80K
Price / share
—
Trade value
—
% of position
7.2%
3/1/2024
246.86K→264.66K
Common Stock
Direct
Shares
+957.00
Price / share
—
Trade value
—
% of position
0.4%
3/1/2024
264.66K→265.62K
Common Stock
Direct
Shares
−274.00
Price / share
$53.69
Trade value
$14.71K
% of position
0.1%
3/1/2024
265.62K→265.34K
Common Stock
Direct
Shares
−1.01K
Price / share
$53.76
Trade value
$54.35K
% of position
0.4%
3/1/2024
265.34K→264.33K
Total
Net shares
+17.47K
Net value
-$69.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2024 | A · Award | +17.80K | — | — | 7.2% | 246.86K | 264.66K |
| Common Stock Direct | 3/1/2024 | A · Award | +957.00 | — | — | 0.4% | 264.66K | 265.62K |
| Common Stock Direct | 3/1/2024 | F · Tax Withholding | −274.00 | $53.69 | $14.71K | 0.1% | 265.62K | 265.34K |
| Common Stock Direct | 3/1/2024 | S · Sale | −1.01K | $53.76 | $54.35K | 0.4% | 265.34K | 264.33K |
| Total | +17.47K | -$69.06K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
31.40K shares
Shares
+31.40K
Strike price
53.69
Held after
31.40K
Exercisable
—
3/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock31.40K shares | 3/1/2024 | A · Award | +31.40K | 53.69 | — | 31.40K |